NOVYX · Research Peptide
CJC-1295 Acetate + Ipamorelin Acetate
Dual-Pathway GHRH Analog Blend for Advanced Metabolic Research
A high-purity lyophilized blend combining CJC-1295, a long-acting GHRH analog, and Ipamorelin, a selective ghrelin-receptor agonist. Developed for controlled in vitro research into GH-axis signaling, receptor selectivity, and related metabolic pathways. Lyophilized for laboratory stability and analytical consistency. For research use only. Not for human or veterinary use.
Pack: 10 mg research format
Technical profile
Product reference
cjc-1295-ipamorelin-10mg
Product group
Peptide
Category
Metabolic
Vial size
10 mg
Purity
99.5%
Form
Lyophilized Powder
Molecular weight
—
Molecular formula
—
Availability
In stock
Featured
Research presentation only. Product handling and laboratory use should follow the supplied technical documentation.
Yes
Published
Yes
Storage
Store lyophilized material at -20°C, sealed and protected from light, heat, and moisture. Avoid repeated freeze-thaw cycles. Keep desiccated for optimal long-term stability.
Handling
Reconstitute aseptically with suitable sterile laboratory diluent. Allow to dissolve with gentle swirling; do not vortex or shake vigorously. Prepare aliquots per laboratory protocol and handle in accordance with research standards. For research use only.
